PeerView Oncology

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

PeerView Oncology

Basic Science
Genitourinary
Breast
Lung
Hematologic Oncology
Gastrointestinal
Events

Playback speed

10 seconds

64 y/o Female With Newly Diagnosed Stage 4 NSCLC, EGFR exon 19 Mutation and Symptomatic Brain Lesions: How Would the Management Change?

By PeerView Oncology FEATURING Sandip Patel, Manmeet Ahluwalia, Kathryn Beal

22 views

May 28, 2020

Comments 0

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Lung

Challenging Case of a 63 y/o Never-Smoking Female With TTF-1+ Lung A…

PeerView Oncology

E. Garon, J. Heymach

248 views

Locally Advanced and Early NSCLC IO Update: Will IO Change the Multi…

PeerView Oncology

B. Stiles

123 views

Managing EGFR+ NSCLC With CNS Metastases: Is There a Difference in C…

PeerView Oncology

S. Patel

388 views

45 y/o With EGFR+ NSCLC and Brain Mets: Should We Consider Mono or C…

PeerView Oncology

S. Patel, M. Ahluwalia, K. Beal

18 views

64 y/o Female With Newly Diagnosed Stage 4 NSCLC, EGFR exon 19 Mutat…

PeerView Oncology

S. Patel, M. Ahluwalia, K. Beal

22 views

Management of EGFR-Mutant Lung Cancer With Central Nervous System Me…

PeerView Oncology

S. Patel, M. Ahluwalia, K. Beal

15 views

41 y/o Female With Newly Diagnosed EGFR+ Stage 4 NSCLC and Brain Met…

PeerView Oncology

S. Patel, M. Ahluwalia, K. Beal

114 views